Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb 18;21(4):1388.
doi: 10.3390/ijms21041388.

Role of VEGFs/VEGFR-1 Signaling and Its Inhibition in Modulating Tumor Invasion: Experimental Evidence in Different Metastatic Cancer Models

Affiliations
Free PMC article
Review

Role of VEGFs/VEGFR-1 Signaling and Its Inhibition in Modulating Tumor Invasion: Experimental Evidence in Different Metastatic Cancer Models

Claudia Ceci et al. Int J Mol Sci. .
Free PMC article

Abstract

The vascular endothelial growth factor (VEGF) family members, VEGF-A, placenta growth factor (PlGF), and to a lesser extent VEGF-B, play an essential role in tumor-associated angiogenesis, tissue infiltration, and metastasis formation. Although VEGF-A can activate both VEGFR-1 and VEGFR-2 membrane receptors, PlGF and VEGF-B exclusively interact with VEGFR-1. Differently from VEGFR-2, which is involved both in physiological and pathological angiogenesis, in the adult VEGFR-1 is required only for pathological angiogenesis. Besides this role in tumor endothelium, ligand-mediated stimulation of VEGFR-1 expressed in tumor cells may directly induce cell chemotaxis and extracellular matrix invasion. Furthermore, VEGFR-1 activation in myeloid progenitors and tumor-associated macrophages favors cancer immune escape through the release of immunosuppressive cytokines. These properties have prompted a number of preclinical and clinical studies to analyze VEGFR-1 involvement in the metastatic process. The aim of the present review is to highlight the contribution of VEGFs/VEGFR-1 signaling in the progression of different tumor types and to provide an overview of the therapeutic approaches targeting VEGFR-1 currently under investigation.

Keywords: Flt-1; PlGF; VEGF-A; VEGFR-1; angiogenesis; cancer; immune escape; melanoma; metastasis.

Conflict of interest statement

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Figures

Figure 1
Figure 1
VEGF family members and their receptors. VEGF-A proangiogenic signaling is mediated via interaction with VEGFR-2 or VEGFR-1. The soluble VEGFR-1 form (sVEGFR-1) functions as a decoy receptor, preventing membrane receptor activation. VEGF-B and PlGF only bind to VEGFR-1, playing a key role in pathological angiogenesis and inflammation. Furthermore, VEGFR-1 activation contributes to the recruitment of tumor-associated macrophages (TAMs) and cancer immune escape. VEGFR-1 and VEGFR-2 activation in tumor cells directly stimulates migration and extracellular matrix (ECM) invasion. VEGF-C and VEGF-D mainly activate VEGFR-3, which is required for developmental and pathological lymphangiogenesis. The VEGF-E, a selective VEGFR-2 ligand, and VEGF-F, a VEGFR-1 and VEGFR-2 ligand, have been omitted from the drawing; VEGF-E is a VEGF homolog of viral origin and VEGF-F is a snake venom VEGF.

Similar articles

See all similar articles

References

    1. Siveen K.S., Prabhu K., Krishnankutty R., Kuttikrishnan S., Tsakou M., Alali F.Q., Dermime S., Mohammad R.M., Uddin S. Vascular Endothelial Growth Factor (VEGF) Signaling in Tumour Vascularization: Potential and Challenges. Curr. Vasc. Pharmacol. 2017;15:339–351. doi: 10.2174/1570161115666170105124038. - DOI - PubMed
    1. Karaman S., Leppänen V.M., Alitalo K. Vascular endothelial growth factor signaling in development and diseas. Development. 2018;145:151019. doi: 10.1242/dev.151019. - DOI - PubMed
    1. De Aguiar R.B., De Moraes J.Z. Exploring the Immunological Mechanisms Underlying the Anti-vascular Endothelial Growth Factor Activity in Tumors. Front. Immunol. 2019;10:1023. doi: 10.3389/fimmu.2019.01023. - DOI - PMC - PubMed
    1. Ferrara N. Vascular endothelial growth factor as a target for anticancer therapy. Oncologist. 2004;9:2–10. doi: 10.1634/theoncologist.9-suppl_1-2. - DOI - PubMed
    1. Maglione D., Guerriero V., Viglietto G., Delli-Bovi P., Persico M.G. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc. Natl. Acad. Sci. USA. 1991;88:9267–9271. doi: 10.1073/pnas.88.20.9267. - DOI - PMC - PubMed
Feedback